Correlation Between Spero Therapeutics and Instil Bio
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Instil Bio, you can compare the effects of market volatilities on Spero Therapeutics and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Instil Bio.
Diversification Opportunities for Spero Therapeutics and Instil Bio
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spero and Instil is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Instil Bio go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Instil Bio
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Instil Bio. But the stock apears to be less risky and, when comparing its historical volatility, Spero Therapeutics is 4.57 times less risky than Instil Bio. The stock trades about -0.13 of its potential returns per unit of risk. The Instil Bio is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,393 in Instil Bio on November 2, 2024 and sell it today you would earn a total of 1,008 from holding Instil Bio or generate 72.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. Instil Bio
Performance |
| Timeline |
| Spero Therapeutics |
| Instil Bio |
Spero Therapeutics and Instil Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Instil Bio
The main advantage of trading using opposite Spero Therapeutics and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
| Instil Bio vs. Assembly Biosciences | Instil Bio vs. Nuvation Bio | Instil Bio vs. Achilles Therapeutics PLC | Instil Bio vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |